Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma
Fumito Abe, Akihiro Kitadate, Sho Ikeda, et al.
Oncotarget (2016) Vol. 8, Iss. 5, pp. 7572-7585
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Histone deacetylase 6 in cancer
Ting Li, Chao Zhang, Shafat Hassan, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 277
Non-Coding RNAs as Mediators of Epigenetic Changes in Malignancies
Subhasree Kumar, Edward A. Gonzalez, Pranela Rameshwar, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3657-3657
Open Access | Times Cited: 90
Histone Deacetylases (HDACs) Guided Novel Therapies for T-cell lymphomas
Qing Zhang, Shaobin Wang, Junhui Chen, et al.
International Journal of Medical Sciences (2019) Vol. 16, Iss. 3, pp. 424-442
Open Access | Times Cited: 78
Mechanism of Action for HDAC Inhibitors—Insights from Omics Approaches
Wenbo Li, Zheng Sun
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1616-1616
Open Access | Times Cited: 60
Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer
M. Janaki Ramaiah, Shaik Mohammad Naushad, Lavanya Ponnusamy, et al.
Gene (2017) Vol. 641, pp. 248-258
Closed Access | Times Cited: 52
Animal Models in Microbeam Radiation Therapy: A Scoping Review
Cristian Fernández-Palomo, Jennifer Fazzari, Verdiana Trappetti, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 527-527
Open Access | Times Cited: 41
Dual strands of pre-miR-150 (miR-150-5p and miR-150-3p) act as antitumor miRNAs targeting SPOCK1 in naïve and castration-resistant prostate cancer
Atsushi Okato, Takayuki Arai, Satoko Kojima, et al.
International Journal of Oncology (2017) Vol. 51, Iss. 1, pp. 245-256
Open Access | Times Cited: 41
MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas
Maria Gluud, Andreas Willerslev-Olsen, Lise Mette Rahbek Gjerdrum, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1229-1229
Open Access | Times Cited: 37
Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases
Abdul Quaiyoom Khan, Fareed Ahmad, Syed Shadab Raza, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 208-226
Open Access | Times Cited: 32
Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma
Jared Andrews, Jennifer A. Schmidt, Kenneth R. Carson, et al.
EBioMedicine (2019) Vol. 46, pp. 170-183
Open Access | Times Cited: 30
Mogamulizumab induces long‐term immune restoration and reshapes tumour heterogeneity in Sézary syndrome*
Marie Roelens, Adèle de Masson, Anaïs Andrillon, et al.
British Journal of Dermatology (2022) Vol. 186, Iss. 6, pp. 1010-1025
Closed Access | Times Cited: 18
Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells
Giulio Bontempi, Michela Terri, Sabrina Garbo, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 16
Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid
Mariah Hoffman, Jessica L.S. Zylla, Somshuvra Bhattacharya, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 756-756
Open Access | Times Cited: 27
Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials
Pan Lai, Yang Wang
Cancer Biology and Medicine (2021) Vol. 18, Iss. 1, pp. 34-51
Open Access | Times Cited: 16
Downregulation of miR‐26 promotes invasion and metastasis via targeting interleukin‐22 in cutaneous T‐cell lymphoma
Yuka Matsuda, Sho Ikeda, Fumito Abe, et al.
Cancer Science (2022) Vol. 113, Iss. 4, pp. 1208-1219
Open Access | Times Cited: 11
What Is New in Cutaneous T Cell Lymphoma?
Sarah Morgenroth, A Roggo, Laura Pawlik, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 11, pp. 1397-1408
Open Access | Times Cited: 6
Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas
Akihiro Kitadate, Sho Ikeda, Fumito Abe, et al.
Haematologica (2017) Vol. 103, Iss. 1, pp. 126-135
Open Access | Times Cited: 21
Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation
Zsuzsanna Gaál
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5838-5838
Open Access | Times Cited: 10
Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect
Masahiro Yamada, Sho Ikeda, Wataru Kuroki, et al.
International Journal of Hematology (2024) Vol. 120, Iss. 3, pp. 325-336
Closed Access | Times Cited: 1
B‐Cell Chronic Lymphocytic Leukemia and B‐Cell Lymphomas: The Key Role of Micro and Long Noncoding RNAs
Mozhdeh Mohammadian, Maryam Salimi, Behrouz Farhadihosseinabadi, et al.
Journal of Clinical Pharmacy and Therapeutics (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Non-coding RNAs in the spotlight of the pathogenesis, diagnosis, and therapy of cutaneous T cell lymphoma
Xiao He, Qian Zhang, Yimeng Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
MicroRNA‑325 inhibits the proliferation and induces the apoptosis of T cell acute lymphoblastic leukemia cells in a BAG2‑dependent manner
Fengyu Wang, Fengli Wang, Shengyu Zhang, et al.
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 6
Open Access | Times Cited: 9
Angiogenesis in cutaneous T‑cell lymphoma ‑ proteomic approaches (Review)
Cristiana Tănase, Ionela Daniela Popescu, Ana‐Maria Enciu, et al.
Oncology Letters (2018)
Open Access | Times Cited: 6
miRNA‑135a regulates Hut78 cell proliferation via the GATA‑3/TOX signaling pathway
Hong Wei, Ruifeng Liu, Xvli Guo, et al.
Molecular Medicine Reports (2019)
Open Access | Times Cited: 6
Challenging Cutaneous T-Cell Lymphoma: What Animal Models Tell us So Far
Antonella Bresin, Elisabetta Caprini, Giandomenico Russo, et al.
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 6, pp. 1533-1540
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top